John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$244M |
| 2 |
Enphase Energy
ENPH
|
+$229M |
| 3 |
GSK
GSK
|
+$223M |
| 4 |
Accenture
ACN
|
+$209M |
| 5 |
Citigroup
C
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$294M |
| 2 |
Amazon
AMZN
|
+$272M |
| 3 |
PayPal
PYPL
|
+$271M |
| 4 |
Bank of America
BAC
|
+$225M |
| 5 |
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 13.7% |
| 3 | Financials | 9.76% |
| 4 | Industrials | 8.72% |
| 5 | Consumer Discretionary | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Vaalco Energy
EGY
$608M
| $2.84M | 0.01% |
+650,663
| New | +$3.34M |
|
|
ETNB
977
DELISTED
89bio
ETNB
| $2.83M | 0.01% |
489,524
+332,610
| +212% | +$1.46M |
|
978
Stratasys
SSYS
$670M
| $2.83M | 0.01% |
196,526
+56,194
| +40% | +$1M |
|
979
Kymera Therapeutics
KYMR
$10.1B
| $2.82M | 0.01% |
129,371
-14,586
| -10% | -$384K |
|
980
Magnolia Oil & Gas
MGY
$6.45B
| $2.78M | 0.01% |
140,468
+92,468
| +193% | +$2.05M |
|
|
EGIO
981
DELISTED
Edgio, Inc. Common Stock
EGIO
| $2.77M | 0.01% |
24,917
-16,194
| -39% | -$1.92M |
|
|
OTLY
982
Oatly Group
OTLY
$507M
| $2.77M | 0.01% |
52,636
-92,844
| -64% | -$6.42M |
|
983
Monolithic Power Systems
MPWR
$63.2B
| $2.76M | 0.01% |
+7,601
| New | +$3.38M |
|
984
Moody's
MCO
$88.6B
| $2.75M | 0.01% |
+11,325
| New | +$3.29M |
|
|
IS
985
DELISTED
ironSource Ltd.
IS
| $2.75M | 0.01% |
800,000
-3,327,931
| -81% | -$12.7M |
|
|
RAD
986
DELISTED
Rite Aid Corporation
RAD
| $2.75M | 0.01% |
555,241
-543,801
| -49% | -$4.22M |
|
|
ARVL
987
DELISTED
Arrival Ordinary Shares
ARVL
| $2.74M | 0.01% |
67,892
-2,870
| -4% | -$189K |
|
988
Revolution Medicines
RVMD
$45.3B
| $2.73M | 0.01% |
138,454
+83,950
| +154% | +$1.84M |
|
989
Tidewater
TDW
$4.62B
| $2.71M | 0.01% |
125,125
+76,345
| +157% | +$1.63M |
|
990
Sibanye-Stillwater
SBSW
$8.82B
| $2.71M | 0.01% |
+291,065
| New | +$2.76M |
|
991
S&T Bancorp
STBA
$1.77B
| $2.7M | 0.01% |
92,218
-38,320
| -29% | -$1.15M |
|
992
ICF International
ICFI
$1.59B
| $2.7M | 0.01% |
24,787
-2,001
| -7% | -$201K |
|
993
Nektar Therapeutics
NKTR
$2.52B
| $2.69M | 0.01% |
56,118
+27,890
| +99% | +$1.66M |
|
994
Travere Therapeutics
TVTX
$6.15B
| $2.69M | 0.01% |
109,166
-91,167
| -46% | -$2.36M |
|
995
Ezcorp Inc
EZPW
$2.15B
| $2.69M | 0.01% |
348,350
+91,524
| +36% | +$758K |
|
996
Viking Therapeutics
VKTX
$3.88B
| $2.68M | 0.01% |
986,323
-55,679
| -5% | -$182K |
|
997
Applied Industrial Technologies
AIT
$12.4B
| $2.68M | 0.01% |
26,034
+1,376
| +6% | +$141K |
|
998
3D Systems Corp
DDD
$518M
| $2.67M | 0.01% |
333,946
-139,592
| -29% | -$1.43M |
|
999
Magnite
MGNI
$3.38B
| $2.66M | 0.01% |
404,994
+69,323
| +21% | +$558K |
|
|
CGAU
1000
Centerra Gold
CGAU
$4.59B
| $2.65M | 0.01% |
600,901
-314,000
| -34% | -$1.63M |
|
Similar funds
John Overdeck's Q3 2022 Portfolio in Review
As of Q3 2022, John Overdeck held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
John Overdeck's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
- John Overdeck added most to GSK in Q3 2022, an estimated $223M increase.
- John Overdeck's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
- John Overdeck fully exited Bank of America in Q3 2022, selling an estimated $225M.
- John Overdeck's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
- John Overdeck opened 582 new positions and closed 600 in Q3 2022.
- John Overdeck's portfolio value fell 2.9% quarter-over-quarter to $29.4B.
Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.